BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6262165)

  • 1. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic potency of inactivated poliovirus vaccines.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency testing of killed polio vaccine in rats.
    van Steenis G; van Wezel AL; Sekhuis VM
    Dev Biol Stand; 1981; 47():119-28. PubMed ID: 6262142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
    van der Marel P; Hazendonk AG; van Wezel AL
    Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M; Ladefoged P; Mathiesen L
    Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
    Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
    Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
    Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
    Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A solid phase radioimmunoassay for poliovirus D-antigen.
    Talbot P
    Dev Biol Stand; 1981; 47():87-90. PubMed ID: 6262164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibody production against poliovirus N and H antigens by immunization of guinea pigs].
    Mietens C; Fuhrmeister U
    Arch Gesamte Virusforsch; 1971; 34(1):23-31. PubMed ID: 4329437
    [No Abstract]   [Full Text] [Related]  

  • 11. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
    Gu FZ; Wang SH; Sun YY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency testing for killed poliomyelitis vaccine.
    Beale AJ
    Dev Biol Stand; 1981; 47():69-75. PubMed ID: 6262161
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between poliovirus and echovirus 6 antigens. I. Immunization experiments in guinea pigs.
    Forsgren M
    Arch Gesamte Virusforsch; 1972; 39(1):108-20. PubMed ID: 4344137
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
    Jiang SD; Pye D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of methods for intratypic differentiation of polioviruses. II. Use of strain-specific antisera cross-adsorbed with antigens of heterologous strains in agar gel diffusion precipitation test for differentiation between wild and vaccine strains of poliovirus typess 1,2 and 3.
    Rubin SG; Chumakov MP; Savinskaya SS; Pervikov YV; Gracheva LA; Voroshilova MK
    Arch Gesamte Virusforsch; 1974; 46(1-2):66-70. PubMed ID: 4374168
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivation of poliovirus with beta-propiolactone.
    Jiang SD; Pye D; Cox JC
    J Biol Stand; 1986 Apr; 14(2):103-9. PubMed ID: 3020055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.